WEDNESDAY, Sept. 12, 2018 -- Researchers say the first drug for children with multiple sclerosis vastly outperformed another common MS medication in a new clinical trial. Fingolimod (Gilenya) reduced relapse rates by 82 percent in patients aged 10... (Source: Drugs.com - Daily MedNews)


Read full article on medworm.com